Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Immunol Lett ; 214: 45-51, 2019 10.
Article de Anglais | MEDLINE | ID: mdl-31491433

RÉSUMÉ

Melatonin has protective effects against inflammation but its role in epididymitis is unknown. We addressed this in the present study using lipopolysaccharide (LPS)-stimulated sheep epididymal epithelial cells as an in vitro inflammation model. We found that interleukin (IL)-1ß, IL-6, tumor necrosis factor α, and cyclooxygenase (COX)-2 mRNA levels; COX-2 and Toll-like receptor (TLR)-4 protein levels; and nuclear factor (NF)-κB p65 phosphorylation were increased by LPS treatment. These effects were reversed in a dose-dependent manner by melatonin (10-11-10-7 M). Quantitative reverse transcription PCR and immunofluorescence analyses showed that the melatonin receptors MT1 and MT2 were expressed in sheep epididymal epithelial cells. The inhibitory effect of melatonin on inflammation was abrogated by the MT1 and MT2 receptor antagonist luzindole and the MT2 ligand 4-phenyl-2-propanamide tetraldehyde. Thus, melatonin exerted anti-inflammatory effect in epididymal epithelial cells by inhibiting TLR4/NF-κB signaling, suggesting its potential as an effective drug for the treatment of epididymitis in sheep.


Sujet(s)
Épididymite/prévention et contrôle , Cellules épithéliales/immunologie , Lipopolysaccharides/toxicité , Transduction du signal/effets des médicaments et des substances chimiques , Animaux , Cellules cultivées , Cytokines/immunologie , Épididyme/immunologie , Épididyme/anatomopathologie , Épididymite/induit chimiquement , Épididymite/immunologie , Épididymite/anatomopathologie , Cellules épithéliales/anatomopathologie , Mâle , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/immunologie , Ovis , Transduction du signal/immunologie , Récepteur de type Toll-4/immunologie , Facteur de transcription RelA/immunologie
2.
Dokl Biochem Biophys ; 484(1): 13-16, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-31012003

RÉSUMÉ

We investigated the role of epiphyseal hormone melatonin in the differentiation of naive CD4+ T cells into regulatory T cells (Treg). The hormone at physiological and pharmacological concentrations inhibited Treg differentiation, decreasing both the proportion of CD4+FOXP3+ cells in the culture and the level of TGF-ß, the key cytokine for this T cell subpopulation. The inhibitory effect of exogenous melatonin was due to its interaction with the membrane receptors MT1 and MT2. At the same time, the signals realized through RORα-the nuclear receptor for melatonin-stimulated Treg formation; however, they were considerably weaker than the signals from the membrane receptors and were overlapped by the latter. Since the Treg subpopulation plays an important role in physiological and pathological processes in the body, the revealed effects of melatonin should be taken into account in its therapeutic use.


Sujet(s)
Différenciation cellulaire/effets des médicaments et des substances chimiques , Mélatonine/pharmacologie , Lymphocytes T régulateurs/immunologie , Adulte , Différenciation cellulaire/immunologie , Femelle , Humains , Membre-1 du groupe F de la sous-famille-1 de récepteurs nucléaires/immunologie , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/immunologie , Lymphocytes T régulateurs/cytologie , Facteur de croissance transformant bêta/immunologie
3.
J Pineal Res ; 66(2): e12540, 2019 Mar.
Article de Anglais | MEDLINE | ID: mdl-30475390

RÉSUMÉ

Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non-24-hour sleep-wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2 , belonging to the G protein-coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2 . Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2 . None of the mABs cross-reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR-KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta-cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies.


Sujet(s)
Anticorps monoclonaux/immunologie , Spécificité des anticorps/immunologie , Récepteur de la mélatonine de type MT1/analyse , Récepteur de la mélatonine de type MT2/analyse , Animaux , Souris , Domaines protéiques , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/immunologie
4.
Bull Exp Biol Med ; 164(4): 462-465, 2018 Mar.
Article de Anglais | MEDLINE | ID: mdl-29504099

RÉSUMÉ

We studied the role of endogenous melatonin in the development and functioning of T cells that produce IL-17 (Th17) and regulatory T cells (Treg) during pregnancy. The study was performed ex vivo and in vitro with auto-serum as the source of endogenous melatonin under conditions of blockade of melatonin-dependent signaling. Participation of the hormone in the regulation of differentiation of both CD4+RORγt+ and CD4+FoxP3+T cells and their key products IL-17A and TGF-ß was demonstrated. It is known that the normal gestational process is accompanied by a decrease in Th17/Treg ratio due to hormonal changes. The sensitivity of the studied subpopulations to melatonin during pregnancy can affect its outcome.


Sujet(s)
Facteurs de transcription Forkhead/immunologie , Régulation de l'expression des gènes/immunologie , Interleukine-17/immunologie , Mélatonine/métabolisme , Lymphocytes T régulateurs/immunologie , Cellules Th17/immunologie , Adulte , Différenciation cellulaire/effets des médicaments et des substances chimiques , Femelle , Facteurs de transcription Forkhead/génétique , Humains , Sérums immuns/composition chimique , Sérums immuns/pharmacologie , Immunophénotypage , Interleukine-17/génétique , Mélatonine/immunologie , Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires/génétique , Membre-3 du groupe F de la sous-famille-1 de récepteurs nucléaires/immunologie , Grossesse , Premier trimestre de grossesse , Troisième trimestre de grossesse , Récepteur de la mélatonine de type MT1/génétique , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/génétique , Récepteur de la mélatonine de type MT2/immunologie , Transduction du signal , Lymphocytes T régulateurs/cytologie , Lymphocytes T régulateurs/effets des médicaments et des substances chimiques , Cellules Th17/cytologie , Cellules Th17/effets des médicaments et des substances chimiques , Facteur de croissance transformant bêta/génétique , Facteur de croissance transformant bêta/immunologie
5.
Zebrafish ; 14(4): 387-389, 2017 08.
Article de Anglais | MEDLINE | ID: mdl-28318435

RÉSUMÉ

Antibodies raised against mammalian proteins may exhibit cross-reactivity with zebrafish proteins, making these antibodies useful for fish studies. However, zebrafish may express multiple paralogues of similar sequence and size, making them difficult to distinguish by traditional Western blot analysis. To identify the zebrafish proteins that are recognized by an antimammalian antibody, we developed a system to screen putative epitopes by cloning the sequences between the yeast SUMO protein and a C-terminal 6xHis tag. The recombinant fusion protein was expressed in Escherichia coli and analyzed by Western blot to conclusively identify epitopes that exhibit cross-reactivity with the antibodies of interest. This approach can be used to determine the species cross-reactivity and epitope specificity of a wide variety of peptide antigen-derived antibodies.


Sujet(s)
Anticorps/immunologie , Cartographie épitopique/méthodes , Protéines de poisson-zèbre/immunologie , Danio zébré/immunologie , Séquence d'acides aminés , Animaux , Spécificité des anticorps , Technique de Western , Histidine/composition chimique , Histidine/métabolisme , Humains , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/immunologie , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/immunologie , Protéines de fusion recombinantes/métabolisme , Similitude de séquences , Petites protéines modificatrices apparentées à l'ubiquitine/génétique , Petites protéines modificatrices apparentées à l'ubiquitine/métabolisme
6.
J Immunol Methods ; 428: 37-41, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26657944

RÉSUMÉ

Antibodies (Abs) specific to cell-surface receptors are attractive tools for studying the physiological role of such receptors or for controlling their activity. We sought to obtain such antibodies against the type 1 receptor for melatonin (MT1). For this, we injected mice with CHO cells transfected with a plasmid encoding human MT1 (CHO-MT1-h), in the presence or absence of an adjuvant mixture containing Alum and CpG1018. As we previously observed that the immune response to a protein antigen is increased when it is coupled to a fusion protein, called ZZTat101, we also investigated if the association of ZZTat101 with CHO-MT1-h cells provides an immunogenic advantage. We measured similar levels of anti-CHO and anti-MT1-h Ab responses in animals injected with either CHO-MT1-h cells or ZZTat101/CHO-MT1-h cells, with or without adjuvant, indicating that neither the adjuvant mixture nor ZZTat101 increased the anti-cell immune response. Then, we investigated whether the antisera also recognized murine MT1 (MT1-m). Using cloned CHO cells transfected with a plasmid encoding MT1-m, we found that antisera raised against CHO-MT1-h cells also bound the mouse receptor. Altogether our studies indicate that immunizing approaches based on MT1-h-expressing CHO cells allow the production of polyclonal antibodies against MT1 receptors of different origins. This paves the way to preparation of MT1-specific monoclonal antibodies.


Sujet(s)
Anticorps/immunologie , Anticorps/isolement et purification , Immunisation , Récepteur de la mélatonine de type MT1/biosynthèse , Récepteur de la mélatonine de type MT1/immunologie , Animaux , Cellules CHO , Cricetulus , Cellules HEK293 , Humains , Souris , Souris de lignée C57BL
7.
J Reprod Immunol ; 92(1-2): 54-61, 2011 Dec.
Article de Anglais | MEDLINE | ID: mdl-21963392

RÉSUMÉ

Daily variation in the peripheral level of melatonin plays a major role in integrating reproduction and environmental information for seasonally breeding birds. However, the variation in immunity and reproduction has never been assessed in any avian species on a 24 h time scale. Therefore, to understand the relationship between immune function and reproductive phases in a seasonally breeding bird, Perdicula asiatica, the Indian jungle bush quail, we studied the daily variation of melatonin and testosterone levels along with expression of their receptors Mel(1a), Mel(1b), and androgen receptor in the spleen during the reproductively active phase. Immunocytochemistry for the melatonin receptors Mel(1a) and Mel(1b) presented a differential distribution pattern. Western blot of splenic protein suggested a daily rhythm of melatonin receptors, while acrophases for the two melatonin receptors Mel(1a) and Mel(1b) differed by 4 h, suggesting that the expression of the receptors may peak at different times, causing more of either Mel(1a) or Mel(1b) to be available at a particular time to mediate function. The circulatory melatonin level correlated with percentage stimulation ratio of splenocytes and plasma interleukin-2 level, but did not correlate with testosterone or androgen receptor, suggesting that melatonin could be a major hormone imparting a time-of-day effect on the modulation of immune function in a seasonally breeding bird during the reproductively active phase.


Sujet(s)
Immunité , Mélatonine/métabolisme , Récepteur de la mélatonine de type MT1/métabolisme , Récepteur de la mélatonine de type MT2/métabolisme , Reproduction , Animaux , Phénomènes chronobiologiques/immunologie , Coturnix , Exposition environnementale/effets indésirables , Immunohistochimie , Interleukine-2/sang , Mélatonine/génétique , Mélatonine/immunologie , Récepteur de la mélatonine de type MT1/génétique , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/génétique , Récepteur de la mélatonine de type MT2/immunologie , Récepteurs aux androgènes/génétique , Récepteurs aux androgènes/immunologie , Récepteurs aux androgènes/métabolisme , Reproduction/physiologie , Saisons , Rate/immunologie , Rate/métabolisme , Testostérone/génétique , Testostérone/immunologie , Testostérone/métabolisme
8.
Scand J Immunol ; 71(6): 420-30, 2010 Jun.
Article de Anglais | MEDLINE | ID: mdl-20500694

RÉSUMÉ

An inverse relation exists between melatonin and androgen in most of the seasonally breeding rodents, but the regulation of their receptors in modulation of immune function has never been reported. The present study accessed the expression pattern of melatonin receptor types (mt1R & mt2R), immune parameters (lymphoid organs weight, leucocyte count, delayed type hypersensitivity and lymphocyte proliferation) in spleen and thymus whereas androgen receptor (AR) expression in thymus of Funambulus pennanti during reproductively active phase. In-vivo melatonin treatment (Mel) and castration (Cx) significantly increased mt1R expression, immune parameters in spleen and thymus but decreased AR expression in thymus only when compared with sham control (Con) squirrels as AR expression was not observed in spleen. Mel alone or in combination with testosterone (T) to Cx squirrels significantly increased mt1R expression, immune parameters in spleen and thymus but decreased AR expression in thymus. T alone in Cx squirrels significantly decreased mt1R expression, immune parameters in spleen and thymus but increased thymic AR expression significantly. In-vitro thymocyte culture supported our in-vivo findings. Mel significantly increased mt1R expression, lymphocyte proliferation, IL-2 secretion but decreased AR expression. T alone significantly decreased aforementioned three parameters but increased AR expression. Combined treatment of Mel and T bring back all parameters to control level. Though we found high mt2R expression, but no significant change has been observed. Thus, present study suggests a clear-cut trade-off relation between mt1R and AR expression that might be acting as an important mediator in seasonal adjustment of immune function in tropical rodents.


Sujet(s)
Récepteur de la mélatonine de type MT1/biosynthèse , Récepteur de la mélatonine de type MT2/biosynthèse , Récepteurs aux androgènes/biosynthèse , Reproduction/immunologie , Sciuridae/immunologie , Animaux , Technique de Western , Test ELISA , Hypersensibilité retardée/immunologie , Immunité cellulaire/immunologie , Interleukine-2/immunologie , Interleukine-2/métabolisme , Numération des leucocytes , Tissu lymphoïde/immunologie , Mâle , Mélatonine/pharmacologie , Récepteur de la mélatonine de type MT1/immunologie , Récepteur de la mélatonine de type MT2/immunologie , Récepteurs aux androgènes/immunologie , Sciuridae/métabolisme , Saisons , Testostérone/pharmacologie , Climat tropical
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE